Axcella Health, Inc.
(NASDAQ : AXLA)

( )
AXLA PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -4.21%212.040.0%$1971.46m
BIIBBiogen, Inc. -0.67%371.901.7%$1288.80m
NVAXNovavax, Inc. -1.10%192.2479.8%$820.37m
SNSSSunesis Pharmaceuticals, Inc. -5.76%11.130.7%$778.03m
AMGNAmgen, Inc. -0.50%238.711.3%$637.40m
BNTXBioNTech SE -2.96%229.500.0%$572.94m
VRTXVertex Pharmaceuticals, Inc. -0.72%187.521.9%$527.63m
GILDGilead Sciences, Inc. -0.60%66.651.0%$475.82m
REGNRegeneron Pharmaceuticals, Inc. -0.79%529.802.7%$386.12m
ILMNIllumina, Inc. 0.74%469.133.5%$346.93m
OCGNOcugen, Inc. 2.02%7.560.0%$345.77m
ALXNAlexion Pharmaceuticals, Inc. 0.11%179.832.0%$331.72m
TXG10X Genomics, Inc. 2.16%201.410.0%$178.72m
EXASEXACT Sciences Corp. 2.37%130.9718.1%$176.05m
BNGOBionano Genomics, Inc. 1.68%7.250.0%$156.12m

Company Profile

Axcella Health, Inc. is a biotechnology company. It engages in the research and development of treatment for diseases and improve health using endogenous metabolic modulator, or EMM, and compositions. Its product pipeline includes AXA1665, for the reduction in risk of recurrent overt hepatic encephalopathy; and AXA1125, for non-alcoholic steatohepatitis. The company was founded by Noubar B. Afeyan, Geoffrey von Maltzahn, and David A. Berry on August 27, 2008 and is headquartered in Cambridge, MA.